Haematology Flashcards
WHEN IN SICKLE CELL DISEASE WOULD YOU USE AN EXCHANGE TRANSFUSION
ACUTE CHEST SYNDROME
STROKE
PRIAPISM
WHAT ARE NEONATAL UNCONJUGATED JAUNDICE CAUSES AFTER 2 W
BREAST MILK
HYPOTHYROIDISM
GI OBSTRUCTION IE PYLORIC STENOSIS
HAEMOLYTIC ANAEMIA
UTI/INFECTIONS
WHAT IS ABO?
WHEN MUM IS BLOOD GROUP O
BABY IS BLOOD GROUP A OR B
MATERNAL ANTIBODIES ATTACK BABYS Hb (ANTI A /ANTI B)
CAUSING HAEMOLYSIS
A PATIENT HAS A Hb COMPOSITION OF HbS AND HbC (although mostly abnormal) WHAT IS THEIR TYPE OF SICKLE CELL DISEASE
HbSC
WHAT IS THE PATHOPHYSIOLOGY OF RBC APLASIA
DECREASED RETICULOCYTES SO DECREASED LEVELS OF HB AND BILLIRUBIN
WHAT ARE THE TREATEMENTS FOR FANCONI ANAEMIA
ANDROGENS
HAEMATIPETIC FACTORS
HAEMATOPOETIC STEM CELL TRANSPLANTS
WHAT IS ALPHA THAMASSEMIA
A REDUCTION IN FUNCTIONING ALPA THAMASSEMIA
WHAT IS THE MANAGEMENT OF ALPHA THAMASSEMIA
TREATED IN MAJOR:
MONTHLY BLOOD TRANSFUSTIONS
HOW DO YOU DIAGNOSE IMMUNE THROMBOCYTOPENIA PURPURA
BLOODS: LOW PLATETLETS,
EXCLUDE:
HIV, CULTURES FOR MENINGITIS, ESR+CRP (SLE), ?BONE MARROW ASPIRATE TO EXCLUDE LEUKEMIA OR BLOOD FILM TO LOOK FOR BLASTOCYSTS
WHAT IS THE PRESENTATION OF FANCONI ANAEMIA
INFERTILITY (DECREASED SPERMATOGENESIS)
INCREASED PREDISPOSITION OF INFECTION
ANAEMIA SYMPTOMS
WHAT IS THE PRESENTATION OF BETA THAMASSEMIA
PROLONGED NEONATAL JAUNDICE
SEVERE ANAEMIC
FAILURE TO TRIVE
WHAT IS BETA THAMASSEMIA
SEVERE REDUCTION IN THE BETA GLOBIN GENE
WHAT IS THE ONGOING MANAGEMENT FOR HAEMOPHILLIA PATIENTS
SEVERE: PROFYLACTIC IV FACTORS 8/9
MODERATE: DESMOPRESSIN
MILD: NOTHING
WHAT IS THE PURPOUS OF VON WILLIBRAND FACTOR
FACILITATES PLATELET ADHESION TO ENDOTHELIUM WHEN DAMAGED ACTING AS A CARRIER FOR CLOTTING FACTORS (8)SO THAT THEY ARENT INACTIVATED AND THEN CLEARED
DESCRIBE WHAT CAN TRIGGER AN APLASITC CRISIS
PARVOVIRUS INFECTION CAUSING DECREASE IN RBC PRODUCTION
WHAT IS THE MANAGEMENT OF SICKLE CELL DISEASE
PROPHYLAXIS: FULL IMMS, DAILY PENICILLIN
DAILY FOLIC ACID
AVOIDING TRIGGERS (COLD, DEHYDRATION)
REGULAR OPHALMOGY CHECKS FOR RETINOPATHY
WHAT IS THE PRESENTATION OF SICKLE CELL DISEASE
ANAEMIA
JAUNDICE
VASOOCCULUSIVE CRISES’
ACUTE ANAEMIC CRISES’
SPLENOMEGALY
WHEN IS RHESUS INCOMPATIBILITY DIAGNOSED
ANTENATALLY
IN PATIENTS WHO HAVE FROQUENCT SICKLE CELL DISEASE CRISES WHAT IS THEIR MANAGEMENT
SAME AS NORMAL PLUS
HYDROUREA (INCREASES HbF)
BONE MARROW TRANSPLANT
WHAT IS THE Hb RANGE FOR NEONATES
(ANAEMIA)
UNDER 14
WHAT ARE CAUSES OF MACROCYTIC ANAEMIA
ALCOHOL (NORMOBLASTIC)
FOLATE (MEGALOBLASTIC)
B12 (PERNACIOUS, MALABSORBTION AND TERMINAL ILEUM)
WHAT IS THE PRESENTATION OF HAEMOPHILLIA
PROLONGED BLEEDING
BRUISING
SECURRENT SPONTANEOUS BLEEDS INTO JOINTS AND MUSCLES CAUSING PAIN
WHAT ARE SIGNS OF FANCONI ANAEMIA
MICROCYTIC
PANCYTOPENIA
THROMBOCYTOPENIA
NEUTROPENIA
WHAT ARE CAUSES OF MICROCYTIC ANAEMIA
IRON DEFICIENCY
THALASSEMIA
SICKLE CELL
CHRONIC DISEASE
WHAT ARE CAUSES OF NORMOCYTIC ANAEMIA
PREGNANCY
HAEMOLYTIC ANAEMIAS
APLASTIC
BLOOD LOSS
CHRONIC DISEASE
WHAT IS VON WILLIBRAND DISEASE
AN AUTOSOMAL DOMINANT DISEASE CAUSING DEFICIENCY OF VON WILLIBRAND FACTOR
WHAT ARE THE TWO TYPES OF HAEMOPHILLIA
ALPHA (FACTOR 8 DEFICIENCY)
BETA (FACTOR 9 DEFICIENCY)
WHAT IS THE TREATEMENT FOR KERNICTUS
PHOTOTHERAPY
BLOOD EXCHANGE TRANSFUSIONS
A PATIENT WITH A PMH OF SICKLE CELL DISEASE PRESENTS TO A + E WITH
- SOB
- FEVER
- COUGH
- PAIN IN CHEST
- LOW O2 SATS
WHATS IS HER DIAGNOSIS
ACUTE CRISIS OF SICKLE CELL DISEASE
- ACUTE CHEST SYNDROME
WHAT IS THE PRESENTATION OF MAJOR ALPHA THAMASSEMIA
OEDEMATUS AND ASCITIS BABY ON 3RD TRIMESTER US
FATAL SHORTLY AFTER BIRTH IN MOST CASES
WHAT SIMPTOM OF HAEMOPHILLIA WOULD CLASSIFY THE HAEMOPHILLIA AS SEVERE
SPONTANEOUS BLEEDS INTO JOITS AND MUSCLES
WHAT SHOULD YOU INVESTIGATE FOR IF IRON DEFICIENCY ANAEMIA IS UNRESPONSIVE TO TREATEMENT
INVESTIGATE FOR COELIAC, MECKELS DIVERTICULUM, GI BLEEDS,OBG CAUSES
WHAT CAN GIVING IV CLOTTING FACTORS CAUSE AS A COMPLIATION
INFECTIONS
DAMAGED PERIFERAL ACCESS
DEVELOPING ANTIBODIES TO FACTORS 8/9
WHAT IS THE MANAGEMENT OF BETA THAMASSEMIA
MAJOR AND INTERMEDIA:
MONTHLY BLOOD TRANSFUSIONS
DESFERROXAMINE
BONE MARROW TRANSPLANT
TRAIT:
TREAT AS ABOVE BUT ONLY IF FERRATIN IS LOW
WHEN IS NEONATAL JAUNDICE PHYSIOLOGICAL
24 H - 2 W